News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CCCC market cap is 124.26M. The company's latest EPS is USD -1.4832 and P/E is -1.16.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.04M | 12.01M | 15.36M | 5.18M | 7.24M |
| Operating Income | -32.22M | -21.44M | -28.24M | -37.71M | -29.16M |
| Net Income | -28.36M | -17.72M | -24.67M | -34.57M | -26.32M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 33.2M | 45.79M | 31.1M | 20.76M | 35.58M |
| Operating Income | -60.45M | -82.13M | -129.53M | -139.03M | -119.61M |
| Net Income | -66.34M | -83.89M | -128.18M | -132.49M | -105.32M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 398.37M | 381.09M | 376.06M | 349.6M | 319.52M |
| Total Liabilities | 140.09M | 134.04M | 133.4M | 133.62M | 124.38M |
| Total Equity | 258.28M | 247.06M | 242.66M | 215.99M | 195.14M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 400.14M | 506.77M | 430.84M | 376.45M | 349.6M |
| Total Liabilities | 119.35M | 117.16M | 141.61M | 130.34M | 133.62M |
| Total Equity | 280.79M | 389.61M | 289.23M | 246.11M | 215.99M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.12M | -23.09M | -47.23M | -65.16M | -33.29M |
| Investing | -53.4M | -65.1M | -64.94M | -51.27M | 29.13M |
| Financing | 34.58M | 34.72M | 45.22M | 45.34M | -46k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -67.25M | -86.97M | -105.94M | -106.84M | -65.16M |
| Investing | -190.51M | -189.34M | 58.42M | 158.35M | -51.27M |
| Financing | 348.93M | 171.4M | 1.15M | 45.49M | 45.34M |
| Market Cap | 124.26M |
| Price to Earnings Ratio | -1.16 |
| Price to Sales Ratio | 3.43 |
| Price to Cash Ratio | 2.2 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 71.01M |
| Average Volume (1 week) | 1.03M |
| Average Volume (1 Month) | 1.4M |
| 52 Week Change | -62.04% |
| 52 Week High | 7.66 |
| 52 Week Low | 1.085 |
| Spread (Intraday) | 0.07 (3.98%) |
| Company Name | C4 Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.c4therapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
